mean that the reference range produced will include only biological variation. Specimens must then be obtained at suitable intervals to allow the calculation of the variation in concentration between individuals, and in one individual during the day, week and, if possible, month and year. With this information it should be possible to decide upon the degree of laboratory precision which is required to detect an abnormality against the reference range of the concentration of a certain substance in the blood of a population, together with that higher precision which is required to distinguish an abnormal change or trend in an individual during a day, from day to day or longer. The laboratory error must be better than the biological variation by a certain factor. Workers at the National Institutes of Health (NIH) have done such an investigation (Young et al. 1971 ) by studying nine healthy subjects weekly for ten weeks, assaying certain blood constituents and calculating the laboratory error and the variations within individuals and between individuals. More recently Westgard et al. (1974) have studied the problem statistically in greater depth.
There are different opinions as to what the factor should be by which the laboratory error should be lower than the personal variation. The allowable error is sometimes termed tolerable analysis variation and the techniques in general use at the NIH at the time of the investigation had an error greater than the biological variation in four cases. Dr E Cotlove of the NIH believed that the error should be less than one half the relevant biological variation. Dr Tonks (1963) proposed a factor of one quarter, but he included laboratory error in the biological variation to which he was referring.
In summary, for clinical chemistry, there are now the means available for determining the degree of accuracy which is required in every foreseeable circumstance, and the possibility of achieving such quality as is necessary is certainly in sight. However, much work lies ahead before these aims can be realized, particularly in the case of those types of assay which have most recently been developed including radioimmunoassays generally, enzymes and certain steroid measurements. 
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Quality Control in Hiematology
Hematology is a discipline which covers a wide range of skills. It uses techniques of analytic biochemistry, physical measurement, microscopy and stain technology, and it is also concerned with the practice of clinical medicine. Thus, quality control in hematology is complex, more so as there are both qualitative and quantitative tests, each of which requires a different approach. By far the greatest workload in the hematology laboratory comes from the blood count which consists of a number of interrelated investigations, so that an assurance of accuracy and reliability in this group of tests is a major requirement in the routine diagnostic laboratory. In fully-automated methods, the control required is of the instrument to ensure that it measures up to the manufacturer's specifications and that it is correctly calibrated. Semi-automated and manual techniques, on the other hand, require assurance of the technical skill of the operator as well as the reliability of the instrument, the reagents and the working standards. Finally, as diagnostic hiematology is above all a visual art based on cell morphology, the making and staining of blood films should also be controlled. Their interpretation requires professional judgment; whether this, too, is an area for surveillance is a more controversial issue which is beyond the scope of this paper.
Quality control has been practised instinctively for many years in haematology: thus, the hmmatologist might repeat a blood count which does not appear to conform to the patient's clinical state or to the blood film appearances. A more formal approach to quality control requires that every factor in a reaction or in the instrument performance be appropriately controlled and that personnel be adequately trained. The quality control procedures which should be adopted are based on the use of control materials, correlation assessments and statistical analysis as set out below.
Quality Control Procedures (1) Instrument calibration: reference preparations; comparison (working) standards; physical standards.
(2) Routine check with control samples: fresh blood; preserved/stabilized blood cells (reference preparations); from previous batch.
(3) Statistical analysis: constancy of resultsabsolute valuesof all specimens and of selected specimens; 'Cusum' on control samples/reference preparations;
Youden plot.
(4) Correlation assessment: cumulative report forms; blood films; clinical situation. (5) Interlaboratory proficiency trials: variance scorescomparison with own previous results, comparison with national results, limits of acceptable range. (6) Staff and instruments: tests on standards, replicate tests; assessment of all steps in test method.
In some respects, quality control programmes are similar for all disciplines, but in hematology there is a particular problem because of the difficulty in establishing reference preparations owing to the relative instability of the blood cells, and, except for hemoglobin, the lack of suitable reference preparations.
Blood Cell Standards
The following are required for an acceptable blood-cell standard:
Characteristics ofa Cell-Counting Standard (1) Stable (2) Direct use (3) Easily suspended (4) Does not aggregate/agglutinate (5) Rheological constants similar to blood (6) Controlled particle size and shape (7) Controlled indices of refraction or specific conductivity of particles and medium (8) Independent methods of assay A large number of materials have been tried, including natural blood cells and artificial materials such as pollens, mould spores, yeast, polystyrene latex and other plastic polymers. None of these has proved suitable. Natural blood has many advantages, but when blood is collected into EDTA and kept at 4°C, it is stable for most tests for only 24-48 hours. Moreover, if stored at room temperature, the red cells swell rapidly, rendering the blood unsuitable for PCV and derived parameters after only a few hours. The stability of blood can be increased by collecting it into a preservative anticoagulant solution. The best medium appears to be acid-citrate dextrose (ACD/NIH-A formula) in which stability of Hb, RBC and PCV can be maintained for several weeks although MCV and MCH values seem less constant (Fig 1) . The use of such preserved blood as a reference preparation or as a control in interlaboratory trials is complicated by the fact that different instruments respond differently to the same preparation. This raises the question whether the reference preparation should be made in accordance with the instrument or vice versa. The concept that a single sample can have different constituents depending upon the instrument with which it is measured is unacceptable, and there is need for calibration procedures to achieve better uniformity in instrument performance. Furthermore, it is important to ensure that measurements will be equally reliable with normal and pathological specimens. For this reason, donkey blood is particularly useful as its red cells are sufficiently small to simulate human microcytes .
As an alternative reference preparation, blood permanently stabilized by fixation has been suggested. Formaldehyde (Benedek 1966 ) and glutaraldehyde (Lewis & Burgess 1966 ) have been used, as has also a fixative solution of acetic acid with sodium sulphate (Torlontana & Tata 1971) . Glutaraldehyde-fixed cells shrink in size during the first few days after preparation, after which they give consistently reproducible measurement of cell numbers and cell-size distribution for months and even years. There are, however, some disadvantages with fixed cell preparations. They have greater viscosity than normal blood and a different relative flow rate (Thom 1972 , Ham et al. 1968 ). In electric counters, this will influence the number of particles passing the counting area in a given time with an obvious effect on the count. Another disadvantage is that in measuring PCV by htmatocrit the rigidity of the fixed cells results in an erroneously high PCV, although the results are consistently reproducible. Thus, although fixed cells have limited value in quality control they are useful as a reference preparation for instrument calibration. Fig 2 Printout results oftrial as issued to a participant in the national interlaboratory quality control scheme much control as the tests for which they are intended. It is necessary to distinguish errors of performance from faulty material and to ensure that storage deterioration does not result in a variability greater than the precision of the instruments which are being controlled. For this, interlaboratory trials at a national level are particularly valuable as they enable rapid distinctions to be made between a batch of deteriorating material and errors due to poor performance in a few individual laboratories. Interlaboratory trials provide essential backup to the experimental work in developing a standard.
To determine the true value of the cell count in a primary standard is a major problem. The only absolute method is by direct counting of the cells in diluted suspension in a heemocytometer counting chamber. This well established procedure can be made sufficiently accurate by using a chamber which conforms to precise specifications and by carrying out a sufficiently large number of replicate counts to minimize errors due to random cell distribution. This is, of course, timeconsuming, but by photographing each area, the count can be made at leisure, methodically and without bias (Dacie & Lewis 1975) .
Reference preparations and comparison standards have stated values and are used primarily for instrument calibration. The same materials, appropriately bottled and labelled, can also be used as control samples for replicate testing within a laboratory, as well as for interlaboratory proficiency trials.
Statistical Quality Control
The most commonly used procedure is based on the principle that for certain tests the normal range remains constant day by day; MCV, MCH and MCHC, for instance, should not vary significantly in healthy individuals or patients with normal hemoglobin. An altered figure for the mean in these parameters will indicate a constant error in the measurement observation, and a high variance in some results or an abnormally wide s.d. suggests random errors in the blood count. It is possible to carry out this control manually, albeit with considerable labour. By using a computer interphased with the cell counter (Bull et al. 1974) , the results can be analysed either in batches or, if online facilities are available, continuously, with the considerable advantage that control failure will be detected while the specimens are still available for repeat tests and before results have been reported.
Another method, and a sensitive one, for demonstrating persistent errors in the blood count procedure is by means of the 'Cusum', applied to the repeated measurements of a control sample or reference preparation (Cavill & Jacobs 1973) . The difference between each measurement and the previous one is scored, taking the plus and minus signs into account. A constant error becomes progressively obvious, whereas random changes tend to cancel each other out and in the stable situation the 'Cusum' oscillates around zero.
A third statistical procedure is to measure paired samples, and to plot the results of each pair on a graph, the values for sample A and sample B being plotted along the abscissa and the ordinate respectively. This is known as the Youden plot (Youden 1969) . Apart from being a concise and convenient way of presentation, the position of the plots on the graph distinguishes between random and systematic errors.
Correlation Assessment
It is essential that adequate records be kept. By using a report form on which results are recorded serially, it is possible to see at a glance if there has been any change in a patient's blood values. The trend of the blood count is even better appreciated when the figures are plotted as a time-related graph. The hmmatologist will be alerted to any unexpected fluctuation which might suggest a failure of accuracy rather than a change in the patient's clinical state.
Examination of the blood film is an essential part of the haematological investigation. Correlation of the blood film with the blood count measurements provides control of these two tests reciprocally. 
Interlaboratory Trials
Interlaboratory trials are essential in order to ensure accuracy and to avoid the situation in which an individual laboratory might have excellent precision but still be way off the target. Also interlaboratory trials allow an assessment of improvement in an individual laboratory relative to its own previous performance and also in relation to a national trend.
In Britain, interlaboratory proficiency trials have been organized since 1968 (Lewis & Burgess 1969) under direction of the British Committee for Standards in Hematology, and now supported by a grant from the Department ofHealth (DHSS). There are approximately 350 participants who receive two specimens for blood counts every month and also material for one or other special investigations (serum B12, iron, abnormal hlmoglobin). Results are returned to the Royal Postgraduate Medical School where they are processed by a series of computer programs (Ward & Lewis 1975) . The data are adjusted to exclude results which are obviously false because of transcription errors and results which are > 3 s.d. in a first computer run. The participants receive a printout of these weighted results (mean and s.d.) of the two samples and of their ratio (Fig 2) . To allow comparison over a range of values without reference to the dimensions of the result, a calculation is used which is known as the variance index (Whitehead et al. 1973) . One unit of variance is equivalent to 1 s.d. irrespective of the dimensions of the test data (Table 1) . When there is a performance fault, analysis of the variance index for each of the individual tests may elucidate the cause of the problem (Fig 3) . As several linked tests constitute the blood count, it has also been useful to summate the variance indices of the individual test to obtain a mean index which reflects overall performance. In addition to the monthly return, the mean variance index is also UVtI Z. reported on a cumulative chart which enables the participant to identify improvement or deterioration with time (Fig 4) . In assessing the significance of the data it is usually assumed that a variance index > 2 or an s.d. > 2 suggests an unsatisfactory performance. However, this statistical procedure is such that 5% of results will always fall outside 2 s.d. no matter how much improvement has taken place. An alternative approach is to establish an acceptable limit of accuracy from results obtained by referee laboratories where the measurements are made under rigidly controlled conditions. It is also necessary to consider the practical significance when an individual measurement deviates significantly from the mean. Thus, when defining the limits of acceptability and satisfactory performance, it is essential to take into account the range of reference values ('normal range') for the particular test and the clinical significance of variation in the test. Quality control and the statistical procedures which are used are not the ultimate objective; their sole purpose is to aid in achieving the accuracy and efficiency that are the essential features of a reliable laboratory. When dealing with a new controversial subject it is sometimes useful to stand back and take an overall view from some distance. I was amused to hear of the latest Martian invasion of earth. Their space-ship hovered over south England and their first report back to base was that the inhabitants of planet earth were metallic rectangular boxes. These proceeded in a regular, orderly fashion and were very colourful. However, they occasionally stopped and shook out parasites. The Martians, being intelligent, quickly recognized the difference between machines and men and further went on to report the presence of many large buildings called factories in which complicated machines were fed with raw materials at one end and produced manufactured goods at the other. There were some special factories where the raw materials were fluids from humans and the products were numerical data. Because the machines did not always work perfectly the machine-minders developed sophisticated statistical techniques to control the quality of the product. My Martians also noticed that there were other human beings who, although they received pieces of human tissue did not produce numerical data; instead they recognized visual patterns in these tissues and combined these findings with information from many different sources to produce a recommendation for action.
What, then, is the connexion between the pattern-recognizing-action-recommending human beings and the machine-minding-data-producing human beings? The answer is, I think, very little except that for historical reasons they frequently work in the same building.
Let me now leave the Martian viewpoint and come down to earth. Is there a place for quality control in any of the functions of the histopathologist? In chemical pathology, for example, we are checking the product that is produced by a technician using a machine. By analogy, in histopathology we might check the quality of the microscopical slide produced. I have heard that some non-histopathologists have suggested that this is what should be done. They advocate a checking system on artifacts and quality control on the depth and hue of staining techniques. However, any experienced pathologist will know that some laboratories produce very pale H & E sections, some produce very dark ones, some produce deep blue and some deep red. Is there a
